2017
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal Of The American Academy Of Dermatology 2017, 78: 70-80. PMID: 29102053, DOI: 10.1016/j.jaad.2017.08.051.Peer-Reviewed Original ResearchConceptsImpact of treatmentPsoriasis Longitudinal AssessmentConventional therapyAdverse eventsDepressive symptomsIncidence rateLongitudinal assessmentConventional systemic therapiesSevere psoriasisBiologic therapySystemic therapyLower incidenceStudy populationPatientsTherapySymptomsPsoriasisRegistryBiologicsPhototherapyDepressionIncidenceMultivariate modelingRiskTreatment
2007
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
Sterry W, Strober B, Menter A, Council O. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. British Journal Of Dermatology 2007, 157: 649-655. PMID: 17627791, DOI: 10.1111/j.1365-2133.2007.08068.x.Peer-Reviewed Original ResearchConceptsMore severe psoriasisStandard of careEvidence-based literatureCardiovascular comorbiditiesImportant healthcare issueSevere psoriasisSystemic inflammationYounger patientsMetabolic syndromeRheumatoid arthritisInsulin resistanceMyocardial infarctionPsoriasisTherapeutic implicationsObesityStrong associationComorbiditiesMedical specialtiesPatientsHealthcare issuesPathophysiologyHealth risksAssociationRiskDyslipidaemia